The Ipsos Almanac
A major Ipsos report concludes that three days a week is optimal for key aspects of workplace culture and performance
Ipsos Karian and Box research finds that three days of office working per week is optimal for key aspects of employee engagement and workplace culture.
Dare to be a TikTok MISFIT: How KitKat shaped a cultural moment and championed Brand Success
In early 2023, KitKat Japan unveiled its noteworthy KitKat YOKUBARI DOUBLE ad on TikTok. Masterfully adhering to social media codes while injecting a burst of creative brilliance resulted in an authentic Misfits story.
Conversations with AI Part II: Unveiling AI quality in qualitative workstreams
In this white paper we explore how generative AI can be used within qualitative research.
Building reputation in 2023: the link between corporate reputation and business efficiency
Drawing on new data from our latest 24-country Global Reputation Monitor, this paper explores the relationship between a good reputation and better business efficiency.
A Woman's Worth: How better portrayal is good for business
It would seem the women’s movement has been running to stand still. In the first volume of Ipsos and Effie UK's Dynamic Effectiveness reports, we demonstrate the commercial upside for showing a woman’s worth.
Very Human Reactions to AI – The impact of cultural expectations and what this means for brands
New thinking from Ipsos, unpacks how brands can implement Generative AI solutions in a way that is authentic, trusted, and brings value to consumers.
Ipsos Update – September 2023
Barbiecore, artificial intelligence, ESG… Ipsos Update explores the latest and greatest research & thinking on key topics from Ipsos teams around the world.
Willingness to Pay: What you need to know when calculating feature willingness to pay
In this paper we will discuss ‘Willingness to Pay’; how to measure it, introducing the latest methods for calculating it, and recommendations based on an extensive evaluation of different methods.
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved – from patients and their carers to cancer treaters to the companies who manufacture and market treatments.
The doctor-patient relationship in the generative AI era
Five reasons why the time to act for pharma is now.